BUND FINANCE

BUND FINANCE › Stocks › ZTS

Zoetis Inc. (ZTS)

NYSE · Stock price, chart and technical analysis

US$85.55+2.07 (+2.48%)

Data from Financial Modeling Prep · Nov 18, 2026, 3:59 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$83.48
OpenUS$82.15
Day rangeUS$82.15 – US$86.58
52-week rangeUS$68.77 – US$132.49
Market capUS$34.76B
Volume4.66M
50-day averageUS$76.66
200-day averageUS$91.08
Beta0.68
Last dividend per shareUS$2.12

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$7.8BUS$8.1BUS$8.5BUS$9.3BUS$9.5B
Net incomeUS$2.0BUS$2.1BUS$2.3BUS$2.5BUS$2.7B
EPS (diluted)4.274.495.075.476.02
Gross margin68.3%67.8%68.3%69.1%70.5%
Operating margin36.1%36.2%35.9%36.7%38.0%
Net margin26.2%26.2%27.4%26.9%28.2%
Free cash flowUS$1.7BUS$1.3BUS$1.6BUS$2.3BUS$2.3B
Total debtUS$6.7BUS$8.1BUS$6.8BUS$6.7BUS$9.3B
CashUS$3.5BUS$3.6BUS$2.0BUS$2.0BUS$2.3B

Compound annual growth: revenue 5.0% · net income 7.0% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E14.6x35.8x27.1x
EV / EBITDA11.1x24.2x16.5x
Operating margin36.3%—3.6%
Net margin26.2%—-0.0%
Debt / equity3.57—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Zoetis Inc.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryUS
CEOKristin C. Peck
Employees14,500
IPO date2013-02-01

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or proto…

www.zoetis.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice